ロード中...
Hepatocellular carcinoma in a gene therapy research subject with ornithine transcarbamylase deficiency
A 66 year old woman who is a manifesting heterozygote for ornithine transcarbamylase deficiency (OTCD) presented with hepatocellular carcinoma (HCC). Fourteen years prior to this presentation she participated in a phase I gene therapy study which used an adenoviral vector, thought to be non-oncogeni...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3273986/ https://ncbi.nlm.nih.gov/pubmed/22129577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2011.10.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|